mTOR inhibitors are the first-choice therapy for renal angiomyolipomas secondary to tuberous sclerosis / Inibidores da mTOR são a primeira escolha no tratamento de angiomiolipomas renais associados à esclerose tuberosa
J. bras. nefrol
; 45(4): 503-505, Dec. 2023. tab
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1528904
Responsible library:
BR1.1
Full text:
Available
Collection:
International databases
Database:
LILACS
Language:
English
Journal:
J. bras. nefrol
Journal subject:
Nephrology
Year:
2023
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal do Paraná/BR